highly significantp = 0.0001
For the 531 melanomas evaluated, the enrichment of BRAF fusions in Spitzoid melanomas (9/12, 75%) compared to non‐Sptizoid tumors (5/519, 1%) was highly significant ( p = 0.0001).
For the 531 melanomas evaluated, the enrichment of BRAF fusions in Spitzoid melanomas (9/12, 75%) compared to non‐Sptizoid tumors (5/519, 1%) was highly significant ( p = 0.0001).